Advertisement
ejvese
Journal Home
Search for

Volume 34, Issue 3, Pages 267-273 (September 2007)


View previous. 5 of 35 View next.

Medical Management of Abdominal Aortic Aneurysm

J. Golledge1a, J.T. Powell2Corresponding Author Informationemail address

Accepted 27 March 2007. published online 04 June 2007.

Medical management of patients with abdominal aortic aneurysm (AAA) is required for several different reasons. Since these patients have an increased risk of cardiovascular death therapy to reduce cardiovascular events is essential. Treatment is in line with the medical management of coronary artery disease including smoking cessation, statins and anti-platelet therapy. Some of these therapies also will slow aneurysm growth. Currently there is no proven focused therapy that reduces aneurysm growth, but the emerging strategies are discussed. Medical management also is required to reduce peri-operative risks and stabilise endovascular aneurysm repair. Whilst some of the therapies targeting cardiovascular risk reduction may be helpful, other emerging strategies are discussed.

1 Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Australia 4811

2 Vascular Surgery Research Group, Imperial College at Charing Cross, St Dunstan's Road, London W6 8RP, UK

Corresponding Author InformationCorresponding author. Professor J.T. Powell, Vascular Surgery Research Group, Imperial College at Charing Cross, St Dunstan's Road, London W6 8RP, UK.

 One of a series of educational articles edited by Janet Powell, UK.

a This author is supported by funding from the National Institute of Health, USA (RO1 HL080010-01) and NHMRC (project grant 379600, fellowship 431503).

PII: S1078-5884(07)00202-X

doi:10.1016/j.ejvs.2007.03.006


View previous. 5 of 35 View next.